Breast Cancer Now said that it was “deeply disappointed” by the decision.
The health regulator has “missed an opportunity” to give women with advanced breast cancer a life-extending drug, a charity has said.
Enhertu is the first licensed targeted treatment for patients with HER2-low breast cancer that cannot be removed surgically or which has spread to other parts of the body, also known as secondary or advanced breast cancer. After the review, Nice concluded that the new criteria “is working as intended and is allowing more medicines for severe, often life-long conditions to be recommended on the NHS”.
“This is in line with the higher value society gives to the important benefits such treatments provide.”
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NHS cancer advice page visited every 16 seconds following Jamie Theakston's cancer diagnosisThe 53-year-old presenter said he sought medical attention after listeners noticed changes to his voice over the past weeks - a common symptom of laryngeal cancer.
Read more »
Black women have a higher risk of dying from all types of breast cancer, meta-analysis revealsBreast cancer is the most diagnosed cancer among U.S. women and the second leading cause of cancer death. Black women who develop breast cancer are around 40% more likely to die of the disease than white women, but it was unclear until now whether this disparity exists across all types of breast cancer.
Read more »
Do cancer and cancer-related treatments increase cardiovascular disease risk in older cancer survivors?A study based on clinical trial data found higher risks of stroke, heart attack, and hospital admission for heart failure in older cancer survivors. In the analysis published in the journal Cancer, chemotherapy was also linked to elevated rates of these conditions.
Read more »
Quality-of-life outcomes reported from trial comparing whole-breast and partial-breast irradiation post-surgeryThe NRG Oncology (NRG)/NSABP B-39/RTOG 0413 clinical trial compared whole-breast irradiation (WBI) to accelerated partial-breast irradiation (APBI) and determined that APBI was not statistically equivalent to WBI in local tumor control. The secondary outcome for the trial was Quality-of-life (QOL).
Read more »
Leicester: NHS apology after baby given wrong breast milkThe parents of baby Milo say he was given stored breast milk from another mother on three occasions.
Read more »
3D mammograms show greater accuracy in detecting breast cancerThe newer, 3D form of breast screening, known as digital breast tomosynthesis (DBT), is more effective at detecting breast cancer than traditional 2D digital mammography (DM).
Read more »